We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LAB market cap is 707.89M. The company's latest EPS is USD -0.2573 and P/E is -9.44.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25.65M | 27.02M | 25.12M | 27.67M | 25.37M |
| Operating Income | -29.03M | -21.11M | -16.59M | -17.45M | -21.17M |
| Net Income | -29.43M | -20.85M | -16.84M | -17.04M | -21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 117.24M | 138.14M | 130.58M | 97.95M | 106.34M |
| Operating Income | -51.84M | -51.04M | -67.46M | -116.21M | -76.6M |
| Net Income | -64.79M | -53.02M | -59.24M | -190.1M | -74.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 414.92M | 390.31M | 371.65M | 355.83M | 339.29M |
| Total Liabilities | 166.41M | 160.52M | 157.55M | 157.96M | 159.75M |
| Total Equity | -62.75M | -81.47M | -97.15M | -113.39M | -131.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 264.81M | 324.76M | 275.21M | 390.31M | 323.07M |
| Total Liabilities | 111.2M | 185.71M | 180.62M | 160.52M | 159.87M |
| Total Equity | 153.61M | 139.05M | 94.6M | -81.47M | -148.05M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -70.19M | -89.37M | -8.49M | -17.81M | -29.23M |
| Investing | -128.37M | -88.13M | 43.15M | 83.28M | 33.35M |
| Financing | 231.03M | 230.76M | -2.56M | -4.64M | -5.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.21M | -15.42M | -44.06M | -89.37M | -43.29M |
| Investing | -39.3M | 39.98M | -11.95M | -88.13M | 20.24M |
| Financing | 2.79M | 20.86M | 15.96M | 230.76M | -6.81M |
| Market Cap | 707.89M |
| Price to Earnings Ratio | -9.44 |
| Price to Sales Ratio | 6.63 |
| Price to Cash Ratio | 13.64 |
| Price to Book Ratio | 4.32 |
| Dividend Yield | - |
| Shares Outstanding | 290.12M |
| Average Volume (1 week) | 2.73M |
| Average Volume (1 Month) | 3.25M |
| 52 Week Change | 45.24% |
| 52 Week High | 3.16 |
| 52 Week Low | 1.46 |
| Spread (Intraday) | 0.18 (7.11%) |
| Company Name | Standard BioTools Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.fluidigm.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
